This document provides interim guidance to countries on testing considerations and strategies for suspect cases of severe acute 
                                                                    ...
                                    
                                        hepatitis of unknown aetiology in children. It is primarily intended for clinical, programmatic, laboratory and diagnostic stakeholders across Member States and national public health authorities involved in the identification and investigation of cases of severe acute hepatitis in children.
This document is part of a package of guidance for this event, which includes suggested minimum reporting variables and a clinical Case Report Form support Member States with case investigation and reporting.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                1PEP GUIDELINES | 2019 EDITION. The prevalence of both HIV and Hepatitis B is high in South Africa therefore there is a significant risk of acquiring these infections following exposure to infected material. Studies suggest that post- exposure proph
                                                                    ...
                                    
                                        ylaxis (PEP) with highly active antiretroviral treatment (HAART) is highly effective in preventing HIV  infection  if  taken  correctly  for  the  full  recommended  duration  of  28  days,  and  that  prophylaxis  with  Hepatitis  B  immunoglobulin  and  vaccination  may  prevent  Hepatitis  B  infection  if  given  soon  after exposure. This update of the Western Cape guidelines for management of potentially infectious exposures  is  based  on  current  evidence  and  guidelines  issued  by  the  WHO,  NDoH  and  the  SA  HIV  Clinicians Society. The key aim is to promote successful completion of the recommended ART regimen in the 28 day period of therapy, as well as prevent infection with Hepatitis B
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Este instructivo se aplica a la implementación del SNVS 2.0 para la notificación de pruebas rápidas para sífilis, vih y/o hepatitis b y c; en los puntos de atención para personas usuarias del s
                                                                    ...
                                    
                                        istema de salud. Éstos pueden ser centros de salud del primer nivel de atención, locales o espacios que brindan las organizaciones de la sociedad 
civil, campañas en la vía pública, espacios educativos, etc. No necesariamente refiere al contexto de los laboratorios convencionales. Se caracterizan por la devolución rápida del resultado a la persona testeada y la posibilidad de tomar una decisión oportuna de inciar un tratamiento y/o proponer medidas preventivas.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                HIV, viral hepatitis and STI epidemics, particularly among people who inject drugs and other key populations, continue to be fuelled by laws and policies 
                                                                    ...
                                    
                                        criminalizing sex work; drug use or possession; diverse forms of gender expression and sexuality; stigma and discrimination; gender discrimination; violence; lack of community empowerment and other violations of human rights. These sociostructural factors limit access to health services, constrain how these services are
delivered and diminish their effectiveness.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultatio
                                                                    ...
                                    
                                        ns and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an outcome. By engaging persons with disabilities in the process, we will also improve the outcomes for persons with disabilities.
The disability community has the slogan “Nothing about us without us,” reminding that we should include and work with persons with disabilities and their representative groups rather than plan or make decisions on their behalf. Persons with disabilities should be engaged throughout shelter programme planning, implementation, monitoring and evaluation.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepati
                                                                    ...
                                    
                                        tis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático, de laboratorio y de diagnóstico de los Estados miembros y a las autoridades nacionales de salud pública que participan en la identificación e investigación de casos de hepatitis aguda grave en niños.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of 
                                                                    ...
                                    
                                        cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infection and associated deaths in adulthood acquired their infection at birth through mother-to-child perinatal transmission or in early childhood.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular 
                                                                    ...
                                    
                                        challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.
Large File: 136 MB!!!!! Please download from the website link!
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                WPSAR Vol 8, No 4, 2017 | doi: 10.5365/wpsar.2017.8.3.005
DOI: http://dx.doi.org/10.5365/wpsar.v8i4.564	
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and 
                                                                    ...
                                    
                                        hepatitis programme managers.
It may also be of interest to managers of maternal, newborn and child health programmes and sexual and reproductive health programmes, international and bilateral agencies, and organizations that provide financial and technical support to the relevant national health programmes. 
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Hindamisaruanne
Juuni 2014
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Der mit Unterstützung der MSD Sharp & Dohme GmbH erstellte Wegweiser enthält grundlegende Informationen zu den Funktionen der Leber wie auch über die viralen Ursachen einer Leberentzündung in Gestalt der Hepatitis A, B, 
                                                                    ...
                                    
                                        C, D und E. Neben allgemeinen Hepatitis-Symptomen, geht der Wegweiser schwerpunktmäßig auf die Schutz- und Behandlungsmaßnahmen der jeweiligen Hepatitis-Typen ein. Abgerundet wird der Wegweiser durch ein Glossar, das die wichtigsten Begriffe knapp erklärt und eine Auswahl an Organisationen, die Hilfe und Rat bei Erkrankungen der Leber anbieten.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Accessed on 20.08.2022
Antirretrovirales de uso general 
Antirretrovirales de uso en pacientes con múltiples fracasos terapéuticos
No antirretrovirales de uso general 
No antirretrovirales de uso nominal 
Medicación para tratamiento de tub
                                                                    ...
                                    
                                        erculosis p.línea 
Medicación para tratamiento de tuberculosis s .línea 
Asistencia nutricional 
Medicamentos para el tratamiento de lepra
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                La Profilaxis Post-Exposición para el VIH (PEP) constituye una herramienta de prevención que consiste en el uso de medicamentos antiretrovirales para reducir el riesgo de infección luego de situa
                                                                    ...
                                    
                                        ciones de potencial exposición del virus. Su incorporación está recomendada por la Organización Mundial de la Salud en el marco de una estrategia de Prevención Combinada1,2. Cuando se inicia dentro de las 72 horas del episodio de potencial exposición al VIH, la PEP reduce en forma significativa el riesgo de transmisión, por lo que su uso se indica en exposiciones ocupacionales y no ocupacionales esporádicas. En la actualidad, una combinación de 3 drogas antirretrovirales durante 28 días es el esquema estándar empleado como PEP2.
A través de la Dirección de Sida, ETS, Hepatitis y TBC, se distribuye la medicación 
necesaria para que la PEP esté disponible en efectores del sistema público de salud cuando está clínicamente indicada.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                Policy Brief.
WHO recommends that pregnant women receive testing for HIV, syphilis and hepatitis B (HBSAg) at least once during pregnancy, preferably in the first trimester.
Dual HIV/syphilis rapid diagnostic tests (RDTs) 
                                                                    ...
                                    
                                        can be used as the first test for pregnant women as part of antenatal care (ANC).
These simple tests can be used at the point-of-care and are cost-saving compared to standard testing in ANC. They enable more women to be diagnosed with HIV and syphilis so that they can access treatment and prevent transmission to their children.
                                    
                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                
                                The updated guidelines present a standard minimum dataset, priority indicators and recommendations to strengthen data use across HIV prevention, testing and treatment, and linkages to services for sexually transmitted infections, viral hepatitis, tu
                                                                    ...
                                    
                                        berculosis and cervical cancer. The guidelines also cover the use of routinely collected data for HIV surveillance (including measurement of HIV prevalence and incidence) and emphasize the use of data from different sources to gain a better picture of epidemiologic trends. The whole collection you can download from here https://www.who.int/publications/i/item/9789240055315
                                    
                                    more